EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry

Tanja Schjødt Jørgensen; Carl Turesson; Meliha Kapetanovic; Martin Englund; Aleksandra Turkiewicz; Robin Christensen; Henning Bliddal; Pierre Geborek; Lars Erik Kristensen

doi:10.1371/journal.pone.0169946

Loading metrics

Open Access

Peer-reviewed

Research Article

EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry

Tanja Schjødt Jørgensen ,

* E-mail: Tanja.Schjoedt.Joergensen@regionh.dk

Affiliation The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
⨯
Carl Turesson,

Affiliations Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, Department of Clinical Sciences, Lund, Section of Rheumatology Lund University and Skåne University Hospital, Lund, Sweden
⨯
Meliha Kapetanovic,

Affiliations Department of Clinical Sciences, Lund, Section of Rheumatology Lund University and Skåne University Hospital, Lund, Sweden, Rheumatology, Department of Clinical Science, Lund University, Lund, Sweden
⨯
Martin Englund,

Affiliation Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences, Lund University, Lund, Sweden
⨯
Aleksandra Turkiewicz,

Affiliation Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences, Lund University, Lund, Sweden
⨯
Robin Christensen,

Affiliation The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
⨯
Henning Bliddal,

Affiliation The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark
⨯
Pierre Geborek,

Affiliations Department of Clinical Sciences, Lund, Section of Rheumatology Lund University and Skåne University Hospital, Lund, Sweden, Rheumatology, Department of Clinical Science, Lund University, Lund, Sweden
⨯
Lars Erik Kristensen

Affiliations The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden
⨯

EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry

Tanja Schjødt Jørgensen,
Carl Turesson,
Meliha Kapetanovic,
Martin Englund,
Aleksandra Turkiewicz,
Robin Christensen,
Henning Bliddal,
Pierre Geborek,
Lars Erik Kristensen

Published: February 2, 2017
https://doi.org/10.1371/journal.pone.0169946

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Rheumatoid arthritis
Is the Subject Area "Rheumatoid arthritis" applicable to this article?

Thanks for your feedback.
Observational studies
Is the Subject Area "Observational studies" applicable to this article?

Thanks for your feedback.
Drug adherence
Is the Subject Area "Drug adherence" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Quality of life
Is the Subject Area "Quality of life" applicable to this article?

Thanks for your feedback.
Sweden
Is the Subject Area "Sweden" applicable to this article?

Thanks for your feedback.
Therapeutic drug monitoring
Is the Subject Area "Therapeutic drug monitoring" applicable to this article?

Thanks for your feedback.